From Linear to Circular Operation: Enhancing Recovery and Efficiency in API Manufacturing

Pharmaceutical manufacturers are losing valuable solvents every day through linear operations. What if those streams could become a source of value instead of waste?

The challenge

Traditional API manufacturing still relies on a “take‑make‑dispose” model. Solvents are used across multiple steps and often end up in waste streams, driving:

• High raw material procurement costs
• Increasing waste treatment expenses
• Higher emissions and regulatory pressure

As sustainability requirements tighten, this linear approach is no longer viable.

The opportunity

Solvents represent one of the largest untapped value streams in pharmaceutical production. By recovering and reusing them, manufacturers can significantly improve both cost efficiency and environmental performance.

The shift towards circular operations is not only a sustainability initiative, but a strategic lever to:

• Reduce operating costs
• Improve resilience against raw material supply risks
• Meet increasingly stringent environmental regulations

The solution

Advanced separation, purification, and emissions management technologies make it possible to close the loop in API manufacturing.

Sulzer combines multiple technologies to address different process challenges:

• High-performance distillation and solvent recovery
  solutions such as DistilCare™ and EXCELOT™ enable the recovery of high‑purity solvents from complex, multi-component mixtures, including heat‑sensitive systems.
• Advanced liquid-liquid extraction
  OptimEXT™ provides recovery beyond conventional distillation limits, particularly for azeotropes and complex systems, while reducing energy consumption.
• Process water treatment and emissions control
  PEMFlux™‑W removes VOCs and reduces the organic load in wastewater streams, delivering compliant discharge.
• Electrified distillation and energy optimization
  VoltaSplit™ supports process electrification, reducing steam usage and lowering CO2 emissions.

The impact

By integrating solvent recovery and process optimization, pharmaceutical producers can unlock measurable results:

• 99% recovery of valuable solvents
• up to 50% reduction in energy consumption
• lower emissions and improved regulatory compliance
• reduced OPEX and improved process efficiency

Enabling circular pharmaceutical manufacturing

Sulzer supports pharmaceutical manufacturers in transforming linear operations into circular, resilient production systems. By combining DistilCare™, EXCELOT™, OptimEXT™, PEMFlux™W, and VoltaSplit™, it becomes possible to maximize the value of process streams while significantly reducing environmental impact.

 Ready to turn solvent waste into value?